Yes, on August 20, the State Organized Drug Joint Purchasing Office released a notice on the Shanghai Sunshine Pharmaceutical Purchasing Network that it had decided to put the third batch of state-organized centralized purchasing of varieties of ibuprofen delayed-release capsules of the winning company North China Pharmaceutical Co. (North China Pharmaceutical, 600812) on the "violation list".
According to the announcement, North China Pharmaceutical failed to supply the agreed purchase volume in Shandong province, and the supply situation has not improved after several interviews and consultations with relevant departments. The enterprise proposed to give up the qualification of winning the selection on August 11, 2021, causing Shandong medical institutions to reflect more concentrated and strong.
Announcement said, according to the third batch of national collection "national drug centralized purchasing document (GY-YD2020-1)" relevant provisions of the national organization of drug joint purchasing office members of the collective deliberation, decided to North China Pharmaceutical Co. The company will be disqualified from participating in the centralized procurement of state-organized drugs from August 11, 2021 to May 10, 2022.
North China Pharmaceutical response
After being canceled 9 months of centralized purchasing declaration qualification, North China Pharmaceutical issued an announcement on August 22 to respond, North China Pharmaceutical in the announcement, explaining that, due to the lack of existing production capacity, the responsibility of the unit of the degree of attention is not enough, the relevant registration and change of the policy adjustments, coupled with the impact of the epidemic, resulting in the company can not guarantee the normal supply.
The company's production capacity is insufficient.
The company in order to minimize the impact on the supply of Shandong Province collection, in August 2021, after communication with the Shandong Provincial Bureau of Medical Protection, by the company proposed to give up the qualification of winning, Shandong Province to invite other enterprises to the product to make up the bid. Recently, Shandong Provincial Medical Protection Bureau has determined the replacement enterprise in accordance with the relevant process, and the replacement enterprise will continue to supply.